These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 892952)

  • 1. [Pharmacokinetics of sulfaclomide in man under therapeutically relevant conditions].
    Meyer FP; Walther H
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):340-5. PubMed ID: 892952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of sulfaclomide and sulfamerazine in patients with impaired renal function after first and after repeated application.
    Traeger A; Stein G
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):315-20. PubMed ID: 892948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the pharmacokinetics of Sulfaclomid, Mebacid, Nevigramon and Metindol in patients with reduced kidney function].
    Traeger A; Stein G
    Z Urol Nephrol; 1978 Apr; 71(4):257-62. PubMed ID: 664911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the kinetics of sulfaclomide and the effect of sulfaclomide therapy on p-aminohippuric acid clearance in pregnancy].
    Peiker G; Traeger A; Nöschel H; Bonow A; Hertel U
    Zentralbl Gynakol; 1975; 97(10):612-8. PubMed ID: 1189751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human pharmacokinetic characteristics of sulfamonomethoxine depending on the drug form].
    Geĭtman IIa; Neugodova NP; Tseĭtlin NN; Kivman GIa
    Farmakol Toksikol; 1979; 42(5):534-7. PubMed ID: 488331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of sulfamerazine, sulfamethoxypyridazine and sulfaclomide in young and adult rats].
    Bräunlich H; Splinter FK
    Acta Biol Med Ger; 1974; 32(2-3):235-47. PubMed ID: 4423849
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacokinetics of sulfalene and sulfamethoxine after combined administration with benzylpenicillin and ampicillin].
    Bobrov VI; Nazarova OI; Agapitova IV; Kalenik NM; Iakovlev VP
    Antibiotiki; 1984 Apr; 29(4):277-82. PubMed ID: 6742805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolism of four sulphonamides in cows.
    Nielsen P
    Biochem J; 1973 Dec; 136(4):1039-45. PubMed ID: 4786525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of certain drugs in the domesticated goat.
    Boulos BM; Jenkins WL; Davis LE
    Am J Vet Res; 1972 May; 33(5):943-52. PubMed ID: 5023053
    [No Abstract]   [Full Text] [Related]  

  • 10. [Individualization of drug dosage by therapeutic monitoring in plasma and the application of pharmacokinetic principles].
    Klotz U
    J Clin Chem Clin Biochem; 1983 Nov; 21(11):649-58. PubMed ID: 6655441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic studies of procainamide (PA) and N-acetylprocainamide (NAPA) in healthy subjects.
    Wierzchowiecki M; Michałowska D; Lowicki Z; Ochotny R; Grześkowiak A; Tomaszkiewicz T
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):272-6. PubMed ID: 6161089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of hepatic and renal disorders on the pharmacokinetics of sulfachloropyridacine.
    Mariño EL; Dominguez-Gil A; Tabernero JM; Macias JG
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):10-4. PubMed ID: 7364528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic effectiveness of sulfanilamides depending on protein binding and the rate of their elimination from the body].
    Makarov VA; Kudrin AN
    Sov Med; 1978 Mar; (3):117-22. PubMed ID: 26115
    [No Abstract]   [Full Text] [Related]  

  • 14. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
    von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E
    Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetic studies on plasma elimination half-life of oxipurinol (author's transl)].
    Lach HJ; Bader B; Schnitker J; Harries EH
    Arzneimittelforschung; 1982; 32(1):76-9. PubMed ID: 7199345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical pharmacokinetics of allopurinol. 2. Allopurinol/oxypurinol pharmacokinetics following allopurinol in single doses and multiple application].
    Fenner H; Schiemann O; Gikalov I
    Arzneimittelforschung; 1985; 35(7):1093-6. PubMed ID: 4052144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of acetylsalicylic acid on sulfalene and sulfadimethoxine binding by serum proteins and on their kinetics in rabbits].
    Bobrov VI; Beletskaia GT; Nazarova OI; Iakovlev VP
    Antibiotiki; 1984 Mar; 29(3):220-3. PubMed ID: 6732209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin pharmacokinetics and dosage requirements in pediatric patients.
    Bendayan R; McKenzie MW
    Clin Pharm; 1983; 2(3):224-35. PubMed ID: 6349908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum protein binding and elimination half-lives of naproxen in patients with hepatocellular or obstructive icterus (author's transl)].
    Held H
    Arzneimittelforschung; 1980; 30(5):843-6. PubMed ID: 7190433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of buflomedil after intravenous administration in patients with chronic renal failure.
    Rey E; d'Athis P; Richard MO; Fillastre JP; Olive G
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):648-52. PubMed ID: 6526539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.